Haemonetics Corporation (HAE) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from Jun 27 2026 to Jun 28 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Haemonetics Corporation  (NYSE: HAE)


Haemonetics's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Haemonetics's ROI in the first quarter of 2026?
Haemonetics Corporation achieved a return on average invested assets (ROI) of 5.05 % in its first quarter of 2026, this is above HAE's average return on investment of 4.55%.
Haemonetics Corporation invested over the 12 months ending in its first quarter of 2026 $1,907 million

ROI fell compared to the fourth quarter of 2026, despite the net income growth of % from the fourth quarter of 2026.

Within the Healthcare sector 111 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 27 2026 quarter, so far to 1486, from total ROI ranking in the fourth quarter of 2026 at 1502.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 27 2026)
I. Quarter		 (Mar 28 2026)
IV. Quarter		 (Dec 27 2025)
III. Quarter		 (Sep 27 2025)
II. Quarter		 (Jun 28 2025)
I. Quarter
Y / Y Investment Change TTM 3.09 % -5.07 % -8.79 % -6.35 % 4.3 %
Y / Y Net Income Change TTM -41.05 % -41.97 % 59.93 % 132.94 % 325.66 %
Investment (TTM) in Millions 2,102 2,016 1,742 1,770 1,803
Return On Investment (TTM) 5.05 % 5.31 % 9.94 % 9.51 % 8.83 %
HAE's Overall Ranking # 1486 # 1502 # 154 # 804 # 840
Seq. Investment Change TTM 4.08 % 3.88 % -0.22 % -4.44 % -4.15 %
Seq. Net Income Change TTM -1.05 % -44.53 % 4.31 % 2.97 % -2.59 %
Net Income (TTM) in Millions 96 97 175 168 163

HAE Company Profile >> Back to HAE Roi Comparisons >> See Annual HAE Return On Investment



Return On Investment HAE's Ranking
Within: No.
Industry # 34
Sector # 112
Overall # 1486

Return On Investment Statistics
High Average Low
11.62 %
4.55 %
-5.5 %
(Jul 02 2011)   (Jul 02 2016)







Financial Statements
Haemonetics's I. Quarter Investments $ 2,102 Millions HAE's Balance sheet
Haemonetics's I. Quarter Income $ 33 Millions Quarterly HAE's Income Statement
HAE's Income by Division See HAE's Income by Division


HAE Annual Return On Investment (Mar 28 2026)
2026		 (Mar 29 2025)
2025		 (Mar 30 2024)
2024		 (Apr 01 2023)
2023		 (Apr 02 2022)
2022
Total Investments in Millions 2,016 1,742 1,758 1,572 1,389
Y / Y Investment Growth 15.72 % -0.88 % 11.79 % 13.2 % -8.79 %
Net Income in Millions 97 168 118 115 43
Y / Y Net Income Growth -41.97 % 42.64 % 1.87 % 166.05 % -45.42 %
Annual Return On Investment 4.83 % 9.63 % 6.69 % 7.34 % 3.12 %


Annual Roi Comment
In the fiscal year 2026 ROI decreased relative to the previous year to 4.83 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HAE's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HAE's Competitors
Subscribers only: Roi for Haemonetics's Suppliers
Subscribers only: Return On Investment for HAE's Customers

Other Ratios
HAE's Roa HAE's Inventory Turnover Ratio HAE's Growth Rates HAE's Dividend Statistics
HAE's Profitability Ratios HAE's Asset Turnover Ratio HAE's Dividend Growth
HAE's Roe HAE's Valuation Ratios HAE's Financial Strength Ratios HAE's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 27 2026, within Healthcare Sector ROI
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %
Msa Safety Inc  13.02 %
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %
Encompass Health Corporation  11.56 %
Embecta Corp   11.20 %
Lemaitre Vascular Inc   11.20 %
3m Company  11.16 %
Globus Medical Inc   11.01 %
National Healthcare Corp  10.91 %
Bioventus Inc   10.85 %
Infusystem Holdings Inc  10.53 %
Livanova Plc  10.40 %
Beone Medicines Ltd   10.32 %
Entrada Therapeutics Inc   10.15 %
Jazz Pharmaceuticals Plc  10.06 %
Prestige Consumer Healthcare Inc   10.06 %
Tactile Systems Technology Inc   10.02 %

Date modified: 2026-09-05T15:12:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.